A joint study conducted by researchers at the Winship Cancer Institute of Emory University and Georgia Institute of Technology demonstrated the possibility of early diagnosis of lung cancer using a breathalyzer-like test. The team identified 75 unique breath volatile organic compounds (BVOCs) that were different in patients with non-small cell lung cancer (NSCLC) compared to individuals without the condition.
To learn more about the study, as well as other lung cancer research conducted by the joint Emory University-Georgia Tech team, please read this article by the Emory News Center.